Roche has appointed Jayson Dallas to take over from John Melville who has retired after 12 years as the general manager of Roche Products.
Dallas officially took over leadership of the company on January 2, 2013, and is based at its Welwyn Garden City site in Hertfordshire.
Dallas said: “The next few years will provide many opportunities for Roche UK and I am excited at the prospect of how we can ensure that more patients can benefit from our innovative medicines as the access to medicines agenda still remains of critical importance.
“I look forward to reconnecting with old colleagues and friends as I return to the UK.”
He qualified as a physician in his native South Africa and has spent over 16 years working in the pharmaceutical industry at companies such as Pfizer and Novartis. During this time he held domestic and global roles in areas such as medical affairs and business leadership.
He previously spent two years at Roche from 1998, serving as an international medical marketing manager and returned to the company in 2010 as head of global product strategy, immunology and ophthalmology at Roche’s Genentech business.
Prior to taking moving to the UK Dallas’ most recent role at San Francisco-based Genentech was to lead its approach to global oncology launch excellence and biosimilar readiness.